--- title: "GREENTOWN CHINA's total contract sales in the first ten months reached RMB 201.1 billion, a decrease of 6.5%" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/264681200.md" description: "GREENTOWN CHINA announced that the total contract sales amount for the first ten months of 2023 was RMB 201.1 billion, a year-on-year decrease of 6.5%. Among them, the sales amount in October was RMB 12.2 billion, with a sales area of approximately 360,000 square meters and an average sales price of RMB 33,936 per square meter. The equity amount attributable to GREENTOWN GROUP was approximately RMB 78.8 billion, with a cumulative contract sales area of approximately 9.69 million square meters" datetime: "2025-11-06T14:38:50.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/264681200.md) - [en](https://longbridge.com/en/news/264681200.md) - [zh-HK](https://longbridge.com/zh-HK/news/264681200.md) --- > 支持的语言: [English](https://longbridge.com/en/news/264681200.md) | [繁體中文](https://longbridge.com/zh-HK/news/264681200.md) # GREENTOWN CHINA's total contract sales in the first ten months reached RMB 201.1 billion, a decrease of 6.5% Greentown China (03900.HK) announced that in October, Greentown Group achieved sales of 2,587 units, with a sales area of approximately 360,000 square meters, and a sales amount of 12.2 billion RMB (the same below), with an average selling price of 33,936 RMB per square meter. In the first ten months, Greentown Group achieved a contracted sales area of approximately 3.51 million square meters, with a contracted sales amount of 120.4 billion RMB. Among them, the equity amount attributable to Greentown Group is approximately 78.8 billion RMB. Including entrusted construction projects, the cumulative total contracted sales area is approximately 9.69 million square meters, with a total contracted sales amount of 201.1 billion RMB, a year-on-year decrease of 6.5% ### 相关股票 - [GREENTOWN CHINA (03900.HK)](https://longbridge.com/zh-CN/quote/03900.HK.md) ## 相关资讯与研究 - [Greentown China overhauls board as long-serving CEO Guo Jiafeng retires](https://longbridge.com/zh-CN/news/281086573.md) - [CSPC Pharmaceutical, Alphamab Oncology's Breast Cancer Drug Study Meets Primary Endpoint](https://longbridge.com/zh-CN/news/281325910.md) - [Wuxi Lead Intelligent Equipment FY net profit amounted to RMB1,559.8 million](https://longbridge.com/zh-CN/news/281053550.md) - [Guotai Haitong Remains a Buy on Jinxin Fertility Group Ltd. (1951)](https://longbridge.com/zh-CN/news/281098586.md) - [CICC Sticks to Its Buy Rating for C&D International Investment Group Ltd. (1908)](https://longbridge.com/zh-CN/news/280899096.md)